[TNF inhibitor (TNFi)]

Insurance delays in juvenile arthritis not impacted by private, public coverage

Children with juvenile idiopathic arthritis who require TNF inhibitors often experience insurance-led delays to therapy initiation, according to a research letter published in JAMA Network Open.
“Although insurance is associated with treatment delays in adults with rheumatoid arthritis, it is unknown if prior authorization (PA) requirements delay [TNF inhibitor (TNFi)] initiation among children with JIA,” Jordan E. Roberts, MD, of Boston Children’s Hospital, and colleagues wrote. “We aimed to characterize delays in TNFi initiation because of insurance among children

[#item_full_content]